XIIlab Co.,Ltd (KOSDAQ:189330)
9,260.00
-480.00 (-4.93%)
Last updated: Jun 26, 2025
XIIlab Co.,Ltd Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 7,588 | 9,093 | 3,663 | 9,897 | 5,778 |
Other Revenue | -0 | - | -0 | - | -0 |
7,588 | 9,093 | 3,663 | 9,897 | 5,778 | |
Revenue Growth (YoY) | 33.21% | 148.22% | -62.98% | 71.29% | - |
Cost of Revenue | 6,046 | 7,783 | 3,475 | 9,424 | 4,402 |
Gross Profit | 1,542 | 1,310 | 188.18 | 473.2 | 1,376 |
Selling, General & Admin | 2,732 | 3,073 | 2,805 | 2,726 | 1,783 |
Research & Development | 2,932 | 3,207 | 3,901 | 2,250 | 1,352 |
Operating Expenses | 5,949 | 6,595 | 7,099 | 5,399 | 3,382 |
Operating Income | -4,407 | -5,285 | -6,911 | -4,926 | -2,006 |
Interest Expense | -73.63 | -81.61 | -112.74 | -145.39 | -151.53 |
Interest & Investment Income | 306.03 | 355.48 | 640.09 | 471.21 | 144.23 |
Earnings From Equity Investments | -163.4 | -200.69 | -145.78 | -75.06 | -63.84 |
Currency Exchange Gain (Loss) | 8.97 | 2.65 | -0.47 | - | 0.93 |
Other Non Operating Income (Expenses) | 34.81 | 22.21 | 67.73 | 106.36 | 192.67 |
EBT Excluding Unusual Items | -4,294 | -5,187 | -6,462 | -4,569 | -1,884 |
Gain (Loss) on Sale of Investments | 0.15 | 1.24 | 0.37 | 24.52 | 9.18 |
Gain (Loss) on Sale of Assets | 185.02 | - | 2.46 | - | -0.28 |
Pretax Income | -4,109 | -5,186 | -6,459 | -4,545 | -1,875 |
Income Tax Expense | 1.09 | 1.09 | - | - | 260.76 |
Net Income | -4,110 | -5,187 | -6,459 | -4,545 | -2,136 |
Net Income to Common | -4,110 | -5,187 | -6,459 | -4,545 | -2,136 |
Shares Outstanding (Basic) | 6 | 6 | 6 | 6 | 6 |
Shares Outstanding (Diluted) | 6 | 6 | 6 | 6 | 6 |
Shares Change (YoY) | 0.06% | 0.28% | 0.80% | 3.75% | - |
EPS (Basic) | -674.65 | -851.37 | -1063.19 | -754.00 | -367.61 |
EPS (Diluted) | -674.65 | -851.37 | -1063.19 | -754.00 | -368.00 |
Free Cash Flow | -4,318 | -4,198 | -5,263 | -5,320 | 471.04 |
Free Cash Flow Per Share | -708.73 | -689.04 | -866.27 | -882.70 | 81.08 |
Gross Margin | 20.32% | 14.41% | 5.14% | 4.78% | 23.82% |
Operating Margin | -58.08% | -58.12% | -188.64% | -49.78% | -34.72% |
Profit Margin | -54.17% | -57.04% | -176.31% | -45.92% | -36.96% |
Free Cash Flow Margin | -56.90% | -46.16% | -143.66% | -53.76% | 8.15% |
EBITDA | -3,445 | -4,234 | -5,703 | -3,748 | -1,194 |
EBITDA Margin | -45.40% | -46.56% | -155.68% | -37.87% | -20.67% |
D&A For EBITDA | 962.45 | 1,051 | 1,207 | 1,178 | 812.04 |
EBIT | -4,407 | -5,285 | -6,911 | -4,926 | -2,006 |
EBIT Margin | -58.08% | -58.12% | -188.64% | -49.78% | -34.72% |
Advertising Expenses | - | 281.67 | 188.37 | 6.26 | 56.83 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.